Skip to main content
Molecular Human Reproduction logoLink to Molecular Human Reproduction
. 2025 Apr 26;31(2):gaaf015. doi: 10.1093/molehr/gaaf015

Roles of chromosomal and gonadal sex in the fetal and placental responses to maternal food restriction in mice

Jess C Hercus 1,#, Daniel Alejandro Salcedo Rubio 2,#, Maria Elisa Osorio Nieto 3, Cheayeong Keum 4, Qi Wang 5, John A Macdonald 6, Jordan S Scott 7, Emily R J Lucas 8, Julian K Christians 9,10,11,12,
PMCID: PMC12085225  PMID: 40286295

Abstract

It is hypothesized that male fetuses are more vulnerable to in utero insults than females due to different growth strategies, and that the placenta contributes to these sex differences. We examined sex differences in the fetal and placental responses to maternal food restriction (∼60% of ad libitum) beginning mid-gestation (Day 11.5). To dissect the roles of chromosomal and gonadal sex, we used the Four Core Genotypes mouse model, which combines deletion of the testis-determining Sry gene from the Y chromosome and autosomal insertion of the Sry gene, such that XX gonadal males and XY gonadal females are produced in addition to XX females and XY males. Food restriction reduced fetal and placental weights but had no effect on the number of viable conceptuses. However, this effect did not differ between gonadal male and female, or between XX and XY, conceptuses. Sex differences in gene expression in both the labyrinth and the combined junctional zone/decidua, as assessed by RNA sequencing, were due entirely to chromosomal sex and not gonadal sex. Food restriction affected the expression of 525 and 665 genes in the labyrinth and the junctional zone/decidua, respectively. However, these effects of food restriction did not differ by gonadal or chromosomal sex when assessed for statistical interactions. In contrast, when analyzing XX and XY placentas separately, hundreds of genes were affected by food restriction in one sex but not in the other, including hundreds of genes not found to be significant in the combined analyses. However, estimated effect sizes were generally similar for XX and XY placentas, suggesting that these sex-stratified analyses greatly exaggerated the extent of sex-dependent responses. Overall, we did not find evidence of the hypothesized sex differences in fetal growth strategy and found that sex differences in placental gene expression were largely due to chromosomal sex.

Keywords: placenta, RNA sequencing, transcriptomics, sex differences, malnutrition, labyrinth, junctional zone, decidua

Graphical Abstract

Graphical Abstract.

Graphical Abstract

Maternal food restriction in the Four Core Genotypes model; the testis-determining Sry gene is on an autosome and deleted on the Y-chromosome (Y), allowing chromosomal sex to be studied independently of gonadal status.

Introduction

Male fetuses are on average heavier than female fetuses beginning in the first trimester (Catalano et al., 1995; Bukowski et al., 2007; Broere-Brown et al., 2016; Kiserud et al., 2017), but also have higher risks of adverse gestational and perinatal outcomes (Stevenson et al., 2000; Challis et al., 2013; Mondal et al., 2014; Verburg et al., 2016; Al-Qaraghouli and Fang, 2017; Broere-Brown et al., 2020; Voskamp et al., 2020). Many authors have suggested that there is a causal link between these two observations, whereby males prioritize growth at the expense of placental development, resulting in increased mortality and susceptibility to prenatal insults, whereas females are more responsive to challenges, reducing growth in the presence of adversity, and thereby reducing mortality and increasing resilience (Clifton, 2010; Eriksson et al., 2010; Sandman et al., 2013; Bale, 2016; Devaskar and Chu, 2016; DiPietro and Voegtline, 2017; Nugent et al., 2018; Pérez-Cerezales et al., 2018; Sutherland and Brunwasser, 2018; Kozhemiako et al., 2020; Meakin et al., 2021).

Such hypothesized sex differences are likely mediated, at least in part by the placenta, which shares the chromosomal complement of the fetus and thus has a sex (Clifton, 2010; Gabory et al., 2013; Rosenfeld, 2015; Tarrade et al., 2015; Bronson and Bale, 2016; Burton et al., 2016; Cheong et al., 2016; Kalisch-Smith et al., 2017; Dearden et al., 2018; Pérez-Cerezales et al., 2018; Meakin et al., 2021; Christians, 2022). However, the mechanisms underlying sex differences in the response to, and long-term effects of, early-life environment are not well known (Christians and Reue, 2023). In mammals, sex differences may be due to chromosomal sex (i.e. XX or XY chromosomes), and/or gonadal sex (i.e. presence of ovaries or testes) with the associated production of sex steroids. In mice, it is possible to distinguish between effects of chromosomal sex and gonadal sex using the Four Core Genotypes (FCG) model (Burgoyne and Arnold, 2016; Mauvais-Jarvis et al., 2017). This model combines a deletion in the testis-determining Sry gene on the Y chromosome (referred to as Y), with an insertion of the Sry gene on an autosome (Arnold, 2020; Reue and Wiese, 2022). When an XY  Sry male is mated with a wild-type XX female, the resulting offspring have four potential genotypes (the FCG): XX Sry males (with testes), XY females (with ovaries), as well as normal XX females and XY  Sry males (carrying Sry on an autosome rather than the Y chromosome). Gonadal sex is thereby independent of the sex chromosome complement. The FCG model has been used extensively to study sex differences in adults but has rarely been applied to prenatal or placental traits (but see Ishikawa et al., 2003).

The goals of the present work were to: (i) assess whether there are sex differences in fetal and placental responses to food restriction, to test the hypothesis that males prioritize fetal growth at the expense of placental development, whereas females are better able to respond to prenatal insults (Meakin et al., 2021); and (ii) use the FCG mouse model to assess the relative contributions of chromosomal complement and fetal gonads to (A) the response to food restriction and (B) sex differences in placental gene expression. In addition to FCG mice, we also included wild-type matings to assess to what extent differences between XX females and XY  Sry males reflect differences between wild-type females and males. As in humans, fetal and placental weights in rodents are generally greater in males than in females (Vickers et al., 2011; Gao et al., 2012; Chin et al., 2017; Christians et al., 2018b; Denisova et al., 2020; Eaton et al., 2020; Phuthong et al., 2020; Bidne et al., 2021). Moreover, while human pregnancies are typically singleton, mouse pregnancies carry multiple fetuses of mixed sex but each fetus is almost always associated with its own placenta, enabling placental function to differ by sex in both cases. As a model of prenatal adversity, we used food restriction beginning in mid-gestation, based on the hypothesis that males ‘invest less in placental growth, which puts them at greater risk of becoming undernourished’ (Eriksson et al., 2010). Furthermore, this timing is common among rodent studies, and food restriction beginning in mid-gestation has relatively consistent sex-dependent effects on adult blood pressure of offspring (Christians et al., 2021). In mice, the differentiation of the gonads occurs between Days 12 and 14 (Wolstenholme et al., 2013), and given the presence of androgen and estrogen receptors within the placenta (McWhorter et al., 2018; Deegan and Engel, 2019; Meakin and Clifton, 2019), both chromosomal complement and fetal gonadal sex may influence the placental response to food restriction occurring in the latter half of gestation. The observations that male fetuses adjacent to females in utero influence the anogenital distance (AGD) of the females (Hotchkiss and Vandenbergh, 2005), and that female fetuses adjacent to males influence the adult behavior of the males (vom Saal et al., 1983), further support the plausibility that gonadal sex may influence tissues beyond the fetus.

Materials and methods

Animals

All work was carried out in accordance with the guidelines of the Canadian Council on Animal Care and approved by the SFU University Animal Care Committee (protocol 1332B-21). Male and female C57BL/6J and FCG mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA, stock numbers 000664 and 010905, respectively). Mice were housed with a maximum of five mice per cage with water and food (5001 LabDiet, St Louis, MO, USA) available ad libitum. Prior to their first mating, females were switched to a breeder diet (Prolab RMH 3000, LabDiet) ad libitum. Female C57BL/6J mice were weighed and placed with a single-housed male (C57BL/6J or FCG) overnight with a maximum of two females per male and separated from the male the next morning (gestational day 0.5). Matings to C57BL/6J and FCG males were carried out using the same cohort of females in the same facility at the same time. Sample sizes are provided in Table 1; we mated more females to FCG males than to C57BL/6J males to obtain roughly similar numbers of fetuses of each genotype (i.e. females mated to FCG males have fetuses of four genotypes, whereas females mated to C57BL/6J males have fetuses of the two wild-type sexes). Pregnancy was determined at Day 11.5 based on weight gain ≥2.5 g. On gestational day 11.5, pregnant females were single-housed and randomly allocated to either the ad libitum diet (control) group, or the food restriction group, which received ∼3.5 g of breeder diet daily. Food consumption was monitored daily; food restriction females had always consumed all food by the following day. Females that were not pregnant at Day 11.5 were paired again. At cull, females ranged in age from 12 to 22 weeks (median 15 weeks) and had been mated one to six (median three) times to achieve pregnancy. The number of pregnancies in each group is provided in Table 1.

Table 1.

Sample sizes.

Treatment Mating type Females Conceptuses XXF XYM XXM XYF
Total
Food restriction FCG 18 146 36 40 37 32
Wild type 11 76 45 31
Control FCG 17a 137 31 37 32 37
Wild type 10 82 36 46
RNA sequencing
Food restriction FCG 18 20 5 5 5 5b
Wild type 10 10 5 5
Control FCG 16 20 5 5 5 5b
Wild type 10 10 5 5

FCG, four core genotypes; XXF, gonadal female with XX chromosomes; XXM, gonadal male with XX chromosomes; XYF, gonadal female with XY chromosomes; XYM, gonadal male with XY chromosomes.

a

In one control FCG female, fetuses appeared normal but were very small (average <0.2 g compared to >0.45 g in next lightest litter); these were excluded from all analyses of fetal and placental traits.

b

Due to removal of outliers (described in text), sample sizes were reduced to four control XYF and four food restriction XYF in the labyrinth, and three control XYF in the junctional zone/decidua.

Sample collection

Mice were culled by cervical dislocation at gestational day 17.5 within 1 min of moving their home cage. The uterus was immediately removed and placed in PBS on ice. The number of viable-appearing conceptuses, and the number of resorbed conceptuses (small, dark masses) were counted. The first two placentas closest to the ovary in one horn of the uterus were immediately dissected in PBS under a digital microscope to separate the labyrinth from the junctional zone and decidua (i.e. junctional zone and decidua were combined), and then the two regions were separately snap frozen in liquid nitrogen. Expression of canonical cell-type markers indicated good tissue separation (Hercus et al., 2024b). Snap-frozen samples were stored at −80°C. The remainder of the uterus was placed in 10% neutral buffered formalin solution at 4°C for 2 days before dissection to weigh the remaining fetuses and placentas. Fetuses were imaged using a digital microscope to measure AGD, crown-rump length, and the length of the head (measured from the tip of the nose through the middle of the eye to the back of the head). A subset of fetuses (two different genotypes from each dam and balanced with regards to treatment and genotype) were selected for dissection to measure kidney size to assess whether this might be associated with effects of prenatal food restriction on offspring adult blood pressure (Christians et al., 2021). Fetal kidneys were imaged using a digital microscope to obtain the 2D areas of the kidney in profile. Researchers were blind to genotype and treatment during fetal measurements. Fetal tail clips were collected for DNA extraction. During dissection of conceptuses for histology, the placental interface with the uterus was kept intact, and placentas were stored in 70% ethanol at 4°C prior to paraffin embedding and sectioning by the Histology Core at the BC Children’s Hospital Research Institute. We analyzed three sections per placenta, taken ∼100 µm apart, beginning at the center of the placenta.

Genotyping

Genomic DNA was extracted from tail clips. For FCG matings, fetal genotype was determined by PCR using the method recommended by the Jackson Laboratory (Protocol 5990). Primers used for the amplification of the Tg(Sry)2Ei transgene were Jax 9371 forward primer: 5′-AGC CCT ACA GCC ACA TGA TA-3′; Jax 9372 reverse primer: 5′-GTC TTG CCT GTA TGT GAT GG-3′; primers used for the detection of the Y chromosome mutation were Jax 9369 forward primer: 5′-CTG GAG CTC TAC AGT GAT GA-3′; Jax 9370 reverse primer: 5′-CAG TTA CCA ATC AAC ACA TCA C-3′); and an internal positive control from our own lab comprised of KO_dist2: 5′-CTC TTG CAT GCC TCC ACT AC-3′; KO_exon2: 5′-GGT CAA ATG AAA CTT CCC TCC-3′). For wild-type matings, fetal sex was also determined by PCR (McFarlane et al., 2013).

RNA extraction

The number of samples selected for RNA extraction and sequencing from each group is provided in Table 1. In all cases, we extracted and sequenced both the labyrinth and junctional zone/decidua from a given placenta, i.e. labyrinth samples and junctional zone/decidua samples are matched. Where possible, we used only one placenta from each dam, but to balance sample sizes it was necessary to use two placentas of different genotypes from each of six dams.

We homogenized placental tissue using zirconium oxide beads (0.5 mm, ZROB05, Next Advance, Troy, NY, USA) and a mechanical shaker (MM300, Retsch, Haan, Germany). Placental mRNA was extracted using the Qiagen RNeasy Plus kit (Qiagen, Hilden, Germany), including gDNA Eliminator columns to remove genomic DNA, according to manufacturer instructions. We assessed RNA concentrations using a Nanodrop spectrophotometer (ND-2000C, ThermoFisher Scientific, Waltham, MA, USA), and RNA was sent to the UBC School of Biomedical Engineering (SBME) Sequencing Core for quality control, library preparation, and sequencing. Sample quality control was performed using the Agilent 2100 Bioanalyzer or the Agilent 4200 Tapestation (Agilent, Santa Clara, CA, USA) and RNA quality was high for all tissues; the median RIN was 9.4 and 9.4, and the lowest RIN value was 8.3 and 7.9 for the labyrinth and junctional zone/decidua, respectively. Samples were then prepped following the standard protocol for the Illumina Stranded mRNA prep (Illumina, San Diego, CA, USA). Sequencing was performed on the Illumina NextSeq2000 with Paired-End 59 bp×59 bp reads, with 20 million paired-end reads per sample. Read sequences were aligned to the Mus musculus (mm10) reference sequence using DRAGEN RNA app on Basespace Sequence Hub. For all samples, over 85% of sequences mapped to transcript fragments (median 92% and 90% for the labyrinth and junctional zone/decidua, respectively), reflecting low gDNA contamination. Sequencing and RNA metrics are provided in Supplementary Tables S1 and S2. Sequencing data are deposited in the GEO database under accession numbers GSE285453 (labyrinth) and GSE291544 (junctional zone/decidua).

Data analysis: pregnancy outcomes and fetal data

All statistical analyses were performed using general linear models (proc GLM), non-parametric Wilcoxon two-sample tests (for the number of fetuses and resorbed conceptuses, proc NPAR1WAY), or repeated measures analyses (proc MIXED) in SAS, Version 9.4 (SAS Institute Inc., Cary, NC, USA). Repeated measures analyses (with dam as a random factor) were used for placental and fetal traits where there were multiple offspring per dam, since the dam was the unit of replication. Specific models are described below.

Data analysis: RNAseq

Gene expression analyses were performed in R (version 4.4.0). Raw count data were extracted from Salmon files using tximport (Soneson et al., 2016), then analyzed with DESeq2 (Love et al., 2014). To remove genes with low expression, we pre-filtered to retain only genes that had a count of at least 10 in at least 10 samples. Analyses were done separately on labyrinth, and junctional zone/decidua. DESeq2 model designs are described below. One sample (F6A, a control XY female) associated with an abnormally small fetus was removed from transcriptomic analyses. In addition, one sample was removed in each of the labyrinth (F41B, a food restriction XY female) and junctional zone/decidua (F46B, a control XY female) based on unusual expression patterns for many genes as assessed by heatmaps. We used a Benjamini–Hochberg false discovery rate-adjusted P-value cutoff of 0.05 to determine significance. Gene enrichment analyses were performed using g: Profiler (Kolberg et al., 2023), using all genes that remained after pre-filtering as the background. Figures were produced using ggplot2 (Wickham, 2016) and VennDiagram (Chen and Boutros, 2011).

Results

Sample sizes are provided in Table 1. Food restriction females were provided with a constant amount of food each day, but control females varied slightly in their daily consumption, such that the amount of food provided to food restriction females was 55, 60, 64, 56, 59, and 66% of that consumed by control females on Days 11.5, 12.5, 13.5, 14.5, 15.5, and 16.5, respectively.

Female traits and pregnancy outcomes

All females identified as pregnant on Day 11.5 based on weight gain were pregnant at cull at Day 17.5, and no females deemed not pregnant were later found to be pregnant. At mating and at Day 11.5, i.e. prior to the food restriction, female weight did not differ between treatment groups (Fig. 1). However, at Day 14.5, 3 days after food restriction had started, food restriction females were significantly lighter (Fig. 1). At cull, food restriction females were ∼6 g lighter, with a ∼4 g difference in the weight of the female without uterus and conceptuses, and ∼2 g difference in the total weight of the uterus and conceptuses (Fig. 1, Table 2). Between mating and cull, control females had gained ∼4.6 g not including the uterus and conceptuses, whereas food-restricted females had not gained significant weight (Table 2). There was no difference in female age between groups (Table 2).

Figure 1.

Figure 1.

Female weight at mating and through pregnancy in control and food restriction females. Blue symbols: control; Red symbols: food restriction. ***P < 0.0001.

Table 2.

Female traits and pregnancy outcomes.

Trait Control (means±SE) Food restriction (means±SE) Difference a (means±SE)
Female age at cull (weeks) 15.4 ± 0.5 15.8 ± 0.5 −0.4 ± 0.7
Female without uterus and conceptuses (g) 24.3 ± 0.4 20.1 ± 0.3 4.2 ± 0.5***
Weight of the uterus and conceptuses (g) 10.1 ± 0.4 8.2 ± 0.4 1.9 ± 0.6**
Female weight gain between mating and cull (not including uterus and conceptuses) (g) 4.6 ± 0.2 0.2 ± 0.2 4.4 ± 0.3***
Number of viable-appearing conceptuses 8.1 ± 0.4 7.6 ± 0.4 0.5 ± 0.5
Number of resorbed conceptuses 0.7 ± 0.2 0.9 ± 0.2 −0.2 ± 0.3
a

Difference between groups is significant at P < 0.01 (**) or P < 0.0001 (***).

The difference in total conceptus weight was not due to a difference in the number of fetuses that appeared viable at dissection (food restriction mean: 7.6, control mean: 8.1, P = 0.61) nor a difference in the number of resorbed conceptuses (food restriction mean: 0.9, control mean: 0.7, P = 0.35). There was no difference between FCG and wild-type matings in the number of fetuses that appeared viable at dissection (FCG mean: 8.1, wild-type mean: 7.5, P = 0.74), or in the number of resorbed conceptuses (FCG mean: 0.8, wild-type mean: 0.9, P = 0.79).

Fetal outcomes

Among fetuses from matings to FCG males, the ratios of the four genotypes did not differ from the expected 1:1:1:1, the ratio of gonadal females to gonadal males did not differ from the expected 1:1, and the ratio of XX to XY did not differ from the expected 1:1 (Table 3). Furthermore, each of these ratios did not differ between food restriction and controls (Table 3). Among matings to wild-type males, the ratio of females to males did not differ from the expected 1:1 (Table 3). The sex ratio tended to be male biased in controls and female-biased in food restriction pregnancies (P = 0.054, Table 3), in contrast to the results in the FCG matings.

Table 3.

Fetal genotype ratios.

Control Food restriction Total
(N/%) (N/%) (N/%)
FCG
XXF 31 (22.6%) 36 (24.8%) 67 (23.8%)
XXM 32 (23.4%) 37 (25.5%) 69 (24.5%
XYF 37 (27.0%) 32 (22.1%) 69 (24.5%)
XYM 37 (27.0%) 40 (27.6%) 77 (27.3%)
XX 63 (46.0%) 73 (50.3%) 136 (48.2%)
XY 74 (54.0%) 72 (49.7%) 146 (51.8%)
Gonadal female 68 (49.6%) 68 (46.9%) 136 (48.2%)
Gonadal male 69 (50.4%) 77 (53.1%) 146 (51.8%)
Wild type
Female 36 (43.9%) 45 (59.2%) 81 (51.3%)
Male 46 (56.1%) 31 (40.8%) 77 (48.7%)

FCG, four core genotypes; XX, FCG animals with XX chromosomes, including both gonadal males and females; XXF, gonadal female with XX chromosomes; XXM, gonadal male with XX chromosomes; XY, FCG animals with XY chromosomes, including both gonadal males and females; XYF, gonadal female with XY chromosomes; XYM, gonadal male with XY chromosomes.

In no case did a chi-square test indicate that genotype ratios differed between treatments, or that genotype ratios differ from expected, i.e. from 1:1:1:1 for FCG or 1:1 for XX vs XY or gonadal females vs gonadal males. However, the difference in the proportions of wild-type males and females between treatments was marginally non-significant (P = 0.054).

To assess whether gonadal sex reflected exposure to gonadal hormones, we measured AGD, a known marker of prenatal androgen exposure (Hotchkiss and Vandenbergh, 2005). We fitted a model including effects of gonadal sex, chromosomal sex, treatment, mating type (FCG vs wild type), and the interaction between gonadal sex and mating type to test whether the difference between gonadal males and gonadal females was as great in FCG fetuses as in wild-type fetuses. The model included the dam as a repeated, random subject to account for non-independence among fetuses from the same dam. AGD was higher in gonadal XX and XY males than in gonadal XX and XY females (F1, 52=224.77, P < 0.0001; Fig. 2A), as expected. There was no effect of mating type on AGD (F1, 52=3.18, P = 0.08), no interaction between mating type and gonadal sex (F1, 52=0.49, P = 0.49), and no effect of chromosomal sex (F1, 53=0.01, P = 0.91). AGD was lower in fetuses exposed to food restriction (F1, 52=10.28, P = 0.002; Fig. 2A) reflecting a smaller size overall (as described in further detail below).

Figure 2.

Figure 2.

Effects of treatment, gonadal sex, chromosomal sex, and mating type (four core genotypes (FCG) or wild type) on fetal traits. Blue symbols: control; Red symbols: food restriction. (A) Anogenital distance (AGD). (B) Fetal weight. (C) Length of the fetal head. (D) Size of the fetal kidney. Plots A and B show average values per dam per genotype and plots C and D show individual fetuses, but all analyses described in text included all individual values and dam as a repeated, random subject. Only P-values for significant terms are shown in the figures; full models are described in the text.

Fetal weight and size: sex differences in response to food restriction?

To assess the effect of food restriction, and whether this depended on gonadal and/or chromosomal effect, we fitted a model including effects of gonadal sex, chromosomal sex, treatment, mating type (FCG vs wild type) and the interactions between gonadal sex and treatment and between chromosomal sex and treatment. As above, the model included the dam as a repeated, random subject to account for non-independence among fetuses from the same dam. Food-restricted fetuses were lighter than controls (F1, 52=15.49, P = 0.0002; Fig. 2B), but there were no interactions between gonadal sex and treatment (F1, 52=0.24, P = 0.63) or between chromosomal sex and treatment (F1, 52=0.01, P = 0.93). XY fetuses (including both gonadal males and females) were slightly heavier than XX fetuses (F1, 52=6.60, P = 0.013). Similar results were obtained for a linear measure of size, crown-rump length (effect of treatment: F1, 52=11.79, P = 0.001; Supplementary Fig. S1). To assess whether food restriction led to asymmetric growth restriction as a result of brain-sparing (Hiersch and Melamed, 2018), we analyzed head length with the model described above and fetal weight as a covariate. The effect of treatment was not significant (F1, 48=3.04, P = 0.09; Fig. 2C), indicating that food restriction fetuses did not have relatively large heads for their body weight, suggesting an absence of brain-sparing in either sex.

Because previous work identified sex-dependent effects of prenatal food restriction on adult blood pressure (Christians et al., 2021), we assessed effects on the size of fetal kidneys. Fetal kidneys were smaller in food-restricted fetuses (F1, 48=32.33, P < 0.0001), but there were no effects of gonadal sex (F1, 34=1.15, P = 0.29) or chromosomal sex (F1, 36=0.82, P = 0.37), and no interactions between gonadal sex and treatment (F1, 34=0.01, P = 0.93) or between chromosomal sex and treatment (F1, 36=0.01, P = 0.94). The reduction in kidney weight in food restriction remained significant (F1, 48=4.46, P = 0.04) when fetal weight was added as a covariate, i.e. kidney size was reduced more than expected given the reduction in fetal weight (Fig. 2D).

Placental weight, efficiency, and histology: sex differences in response to food restriction?

The same analysis was performed for placental weight. The effect of treatment (F1, 49=10.88, P = 0.0018) was significant, with food-restricted placentas lighter than controls (Fig. 3A), but again there were no interactions between gonadal sex and treatment (F1, 43=0.22, P = 0.64) or between chromosomal sex and treatment (F1, 45=0.25, P = 0.62). Both gonadal male and female XY placentas were significantly heavier than XX placentas (F1, 45=10.15, P = 0.0026), but there was no effect of gonadal sex (F1, 43=1.26, P = 0.27; Fig. 3A). FCG placentas were lighter than wild-type placentas (F1, 49=15.58, P = 0.0003; Fig. 3A).

Figure 3.

Figure 3.

Effects of treatment, gonadal sex, chromosomal sex, and mating type (four core genotypes (FCG) or wild type) on placental traits. Blue symbols: control; Red symbols: food restriction. (A) Placental weight. (B) Relationship between placental weight and fetal weight. (C) Area of the junctional zone. (D) Area of the labyrinth. Plot A shows average values per dam per genotype, while plot B shows individual fetuses, but analyses described in text included all individual values and dam as a repeated, random subject. Only P-values for significant terms are shown in the figures; full models are described in the text. Plots C and D present average values per placenta.

To assess placental efficiency while avoiding problems associated with the use of the ratio of fetal weight to placental weight (Christians et al., 2018a), we repeated the analysis of fetal weight described above and included placental weight as a covariate. Food restriction fetuses remained smaller than controls, when controlling for placental weight (F1, 49=18.41, P < 0.0001; Fig. 3B), reflecting lower fetal weight for a given placental weight, i.e. lower placental efficiency.

We assessed the area of the labyrinth and the junctional zone in a subset of samples (N = 5 per genotype/treatment for a total of 60 placentas); representative images of placental histology are shown in Supplementary Fig. S2. The area of the junctional zone showed a significant interaction between chromosomal sex and treatment (F1, 52=4.80, P = 0.033), whereby XY control placentas had larger junctional zones than the other groups (Fig. 3C). In contrast, the area of the labyrinth did not show such an interaction (F1, 52=1.38, P = 0.25), or an effect of treatment (F1, 52=2.09, P = 0.15; Fig. 3D).

Placental gene expression: sex differences in response to food restriction?

We aimed to analyze gene expression in only one placenta from each dam (sampling from the two placentas closest to one of the ovaries), but it was necessary to use two placentas of different genotypes from each of six dams to balance sample sizes (Table 1). In the labyrinth and in the junctional zone/decidua, 17 106 and 16 388 transcripts remained after pre-filtering, respectively. Across all samples, transcriptomic signatures were >96% similar in both tissues (Supplementary Fig. S3). For both tissues, we fitted a model in DESeq2 including gonadal sex, chromosomal sex, treatment, mating type, and the interactions between gonadal sex and treatment, and between chromosomal sex and treatment, as well as the number of unique reads in each sample identified by DRAGEN (scaled to a z-score), as this was associated with the first principal component of the count data. In both the labyrinth and the junctional zone/decidua, few genes showed an interaction between chromosomal sex and treatment, or an interaction between gonadal sex and treatment (Table 4).

Table 4.

Number of differentially expressed genes.

Labyrinth Junctional zone/decidua
Number of DEG Number of DEG
Treatment (food restriction vs control) 525 665
Chromosomal Sex (XX vs XY) 30 18
Gonadal sex (gonadal male vs female) 0 0
Mating type (C57BL/6J vs FCG) 2 1
Treatment × chromosomal sex interaction 1 0
Treatment × gonadal sex interaction 0 1

DEG, differentially expressed genes; FCG, four core genotypes.

Placental gene expression: effects of food restriction

Food restriction was associated with the upregulation of 251 and 371 genes in the labyrinth (Fig. 4A and B) and junctional zone/decidua (Fig. 5A and B), respectively (Table 4; Supplementary Tables S3 and S4). Among these genes, enriched gene ontology terms and KEGG pathways were very general (e.g. ‘molecular function’; Fig. 6A). In the labyrinth (Fig. 4A and B) and junctional zone/decidua (Fig. 5A and B), food restriction was associated with the downregulation of 274 and 294 genes, respectively (Table 4; Supplementary Tables S3 and S4). In both tissues, these genes were enriched for terms related to immune function (Fig. 6B). Despite some similarities in enriched pathways, relatively few of the genes affected by food restriction (<20%) were common to both the labyrinth and junctional zone/decidua (Fig. 7A and B). Nutrient transporters previously found to be affected by food restriction, such as Slc2a1, Slc2a3, Slc38a1, Slc38a2, Slc38a4, and Got2 (Fabppm) (Coan et al., 2010; Sferruzzi-Perri et al., 2011; Ganguly et al., 2014; Connor et al., 2020; Eaton et al., 2020; Van Gronigen Case et al., 2021), and the stress-responsive Ogt, were not among genes differentially expressed by treatment in either tissue (Supplementary Tables S3 and S4). Despite the large number of genes differentially expressed by treatment, principal component analysis (PCA) plots did not show clear separation between control and food restriction samples (Figs 4C and 5C), likely because relatively few genes showed large changes in expression (Figs 4B and 5B). Furthermore, in both tissues, many differentially expressed genes had low expression levels, and large absolute log-fold changes (>4) were only seen in the genes with very low expression (Figs 4D and 5D).

Figure 4.

Figure 4.

Effects of food restriction on gene expression in the labyrinth. (A) Heat map of genes differentially expressed. (B) Volcano plot; gene names are provided where the absolute log2-fold change was >2. (C) Principal component (PC) analysis of labyrinth samples, based on the top 500 most variable genes after variance stabilizing transformation (VST) by DESeq2. (D) MA plot; gene names are provided where the absolute log2-fold change was >1 and the log2 mean expression was >7.

Figure 5.

Figure 5.

Effects of food restriction on gene expression in the junctional zone/decidua. (A) Heat map of genes differentially expressed. (B) Volcano plot; gene names are provided where the absolute log2-fold change was >2. (C) Principal component (PC) analysis of junctional zone/decidua, based on the top 500 most variable genes after variance stabilizing transformation (VST) by DESeq2. (D) MA plot; gene names are provided where the absolute log2-fold change was >1 and the log2 mean expression was >8.

Figure 6.

Figure 6.

Functional enrichment analysis of genes affected by food restriction. (A) Genes upregulated and (B) genes downregulated by food restriction in the labyrinth and junctional zone/decidua, including gene ontology (GO) terms for biological processes (BP) and molecular functions (MF), as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.

Figure 7.

Figure 7.

Overlap in effects of food restriction or chromosomal sex between the labyrinth and junctional zone/decidua. (A) Overlap in genes upregulated by food restriction. (B) Overlap in genes downregulated by food restriction. (C) Overlap in genes upregulated in XY tissues. (D) Overlap in genes downregulated in XY tissues.

Placental gene expression: relative contributions of chromosomal and gonadal sex

No genes showed differential expression by gonadal sex (Table 4). In contrast, in the labyrinth (Fig. 8) and junctional zone/decidua (Fig. 9), 17 and 9 genes were upregulated in XY compared to XX, respectively, whereas 13 and 9 genes were downregulated in XY, respectively (Table 4; Supplementary Tables S5 and S6). Of these, 10 and 8 were on the X chromosome and 6 and 4 were on the Y chromosome in the labyrinth and junctional zone/decidua, respectively. Many of these genes were common to both the labyrinth and junctional zone/decidua (Fig. 7C and D); only one of the genes in common, Sohlh2, is not located on a sex chromosome. One X chromosome gene (Eif2s3x) and some of the Y chromosome genes (Ddx3y, Kdm5d, Eif2s3y, Uty) differentially expressed by chromosomal sex are members of homologous X–Y pairs that may act to maintain gene dosage (Bellott et al., 2014). The gene encoding O-linked N-acetylglucosamine transferase (Ogt), which is known to escape X chromosome inactivation and be responsive to stress (Howerton et al., 2013), was more highly expressed in XX mice in both tissues, as expected, but did not show an interaction between chromosomal sex and treatment. Two X-linked genes, Msl3 and Hccs, were more highly expressed in XY mice, reflecting a known translocation from the X chromosome to the FCG Y chromosome (Panten et al., 2024). In the labyrinth, XX and XY samples showed clear separation by PC2 (Fig. 4C), perhaps because of a few genes with large differences between XX and XY (Fig. 8), although such separation was not observed in the junctional zone/decidua (Fig. 5C).

Figure 8.

Figure 8.

Effects of chromosomal sex on gene expression in the labyrinth. (A) Heat map of genes differentially expressed. (B) Volcano plot; gene names are provided where the absolute log2-fold change was >2.

Figure 9.

Figure 9.

Effects of chromosomal sex on gene expression in the junctional zone/decidua. (A) Heat map of genes differentially expressed. (B) Volcano plot; gene names are provided where the absolute log2-fold change was >2.

Placental gene expression: expression of sex steroid receptors

Given the lack of effects of gonadal sex on gene expression, we examined expression levels of the sex steroid receptors. In the labyrinth, the expression of the androgen receptor (Ar), estrogen receptor 1 (alpha) (Esr1), estrogen receptor 2 (beta) (Esr2), and G protein-coupled estrogen receptor 1 (Gper1) was either very low or not detected (Fig. 10), whereas in the junctional zone/decidua samples, there was moderate expression of Esr1 and low expression of Ar (Fig. 10). The glucocorticoid receptor (Nr3c1), for which binding sites are enriched among genes affected by sex steroids in mouse liver and adipose tissue (Blencowe et al., 2022), was highly expressed in both the labyrinth and the junctional zone/decidua (Fig. 10).

Figure 10.

Figure 10.

Expression levels of the steroid hormone receptors. Normalized counts of androgen receptor (Ar), estrogen receptor 1 (alpha) (Esr1), estrogen receptor 2 (beta) (Esr2), G protein-coupled estrogen receptor 1 (Gper1), and glucocorticoid receptor (Nr3c1) in the labyrinth and junctional zone/decidua.

Validation of effects of treatment and chromosomal sex on placental gene expression

To validate our DEG results and the combined analyses of FCG and wild-type samples, we analyzed samples sired by FCG and wild-type males separately. Among genes differentially expressed in the combined analyses, the log2-fold changes in FCG samples were strongly correlated with the log2-fold changes in wild-type samples for both the effects of treatment and chromosomal sex, in both the labyrinth and the junctional zone/decidua (Figs 11 and 12), i.e. the results were largely consistent in two independent sets of samples.

Figure 11.

Figure 11.

Consistency of effects of treatment and chromosomal sex in the labyrinth when four core genotypes (FCG) and wild-type samples were analyzed separately. (A) Effects of treatment. (B) Effects of chromosomal sex. Only genes showing significant differential expression in the combined analysis are included. Symbol color indicates whether effect was significant in both FCG and wild-type sub-analyses (yellow), significant in wild type but not FCG (blue), significant in FCG but not wild type (red), or not significant in either of the sub-analyses, but significant in the combined analysis (black). Gene names are provided where the absolute log2-fold change in the combined analysis was >1.5.

Figure 12.

Figure 12.

Consistency of effects of treatment and chromosomal sex in the junctional zone/decidua when four core genotypes (FCG) and wild-type samples were analyzed separately. (A) Effects of treatment. (B) Effects of chromosomal sex. Only genes showing significant differential expression in the combined analysis are included. Symbol color indicates whether effect was significant in both FCG and wild-type sub-analyses (yellow), significant in wild type but not FCG (blue), significant in FCG but not wild type (red), or not significant in either of the sub-analyses, but significant in the combined analysis (black). Gene names are provided where the absolute log2-fold change in the combined analysis was >1.5.

Sex-stratified analyses of placental gene expression

Our finding that there were no interactions between treatment and gonadal or chromosomal sex is at odds with many previous studies reporting numerous sex-specific effects. However, many previous studies have analyzed the sexes separately, rather than explicitly testing whether effects of treatment were significantly different between the sexes, and this may inflate the rate of false positives (Chin and Christians, 2015; Christians et al., 2021; Christians and Chow, 2022). To investigate this possibility, we repeated our analyses separately by chromosomal sex, since we found more differences in gene expression by chromosomal sex than by gonadal sex. In both tissues, the sex-stratified analyses found hundreds of genes to be differentially expressed in response to treatment in one sex but not the other, including hundreds of genes that were not found to be significant in the combined analyses (Fig. 13A and B). These ‘sex-specific’ effects could be false positives or, alternatively, could be due to insufficient power to detect real interactions between sex and treatment. To assess this, we examined the distribution of the difference in log2-fold changes between XX and XY samples and found that these were generally quite close to zero (Fig. 13C and D), indicating that, even if some of the ‘sex-specific’ effects are real, there are few genes with a substantially different response in males and females.

Figure 13.

Figure 13.

Effects of treatment on placental gene expression from analyses stratified by chromosomal sex, including both four core genotypes (FCG) and wild-type samples. (A) Venn diagram of the overlap in genes significantly affected by treatment (food restriction vs control) in the labyrinth in separate analyses for each chromosomal sex and in the combined analysis including both XX and XY. (B) Overlap in genes significantly affected by treatment in the junctional zone/decidua. (C) Distribution of the difference in estimated effect of treatment (log2-fold change) in the labyrinth between XX and XY placentas among genes significant in XX but not XY placentas (above, blue), and vice versa (below, red). (D) Distribution of the difference in estimated effect of treatment between the chromosomal sexes in the junctional zone/decidua.

Discussion

Sex differences in fetal and placental responses to food restriction

Our first goal was to test the hypothesis that males prioritize fetal growth at the expense of placental development, whereas females are better able to respond to prenatal adversity. Our model of prenatal adversity, maternal food restriction beginning in mid-gestation, reduced maternal weight, fetal weight, and size as well as placental weight, without affecting the number of fetuses that appeared viable. Despite treatment itself having clear effects, the effects on fetal and placental weights did not depend on gonadal or chromosomal sex. In our previous systematic review and meta-analysis (Christians et al., 2021), we similarly found that food restriction in the latter half of gestation in rats consistently reduced birthweight, but that these effects did not differ between the sexes. Undernutrition also affects fetal growth in both sexes in the mouse (Goyal et al., 2013; Eaton et al., 2020). The only consistent sex-dependent effect of prenatal food restriction that we observed in our previous review was an increase in adult blood pressure, with males affected to a greater extent than females (Christians et al., 2021). Given this latter observation, in the present study, we examined fetal kidney size to test the hypothesis that kidney development and nephron complement underlie the effects of food restriction on blood pressure (Morton et al., 2016). We observed that fetal kidney size was disproportionately reduced by food restriction, i.e. to a greater extent than expected given the effect on fetal weight, but this effect was not sex dependent.

In contrast, the junctional zone area of XY placentas was more responsive to food restriction than it was in XX placentas, with larger junctional zones in XY control placentas, and no difference between the sexes in food restriction. This finding is inconsistent with the hypothesis that males prioritize fetal over placental growth and are less able to respond to insults. Previous work has similarly found maternal protein restriction to reduce the junctional zone but not the labyrinth (Sferruzzi-Perri et al., 2011; Gonzalez et al., 2016), and found junctional zone areas to be smaller in female placentas than in male placentas among controls (Eaton et al., 2020).

Few genes showed interactions between treatment and gonadal or chromosomal sex in expression levels. We thus found little support for the hypothesized sex differences in fetal growth strategies. While some authors report extensive sex-specific effects in the placenta, rather than testing for interactions between sex and treatment, many such studies analyze the sexes separately, which is an approach that can greatly inflate the number of false positives (Christians et al., 2021; Christians and Chow, 2022). This was illustrated by our sex-stratified analyses, which found hundreds of genes to be significantly affected by food restriction in one sex but not the other, even though differences in effect size between the sexes (measured as log2-fold change) were generally small.

Relative contributions of chromosomal and gonadal sex

Our second goal was to use the FCG mouse model to assess the relative contributions of chromosomal complement and fetal gonads to sex differences in placental gene expression, which have not been investigated previously. Genotype ratios did not vary from expected, and the number of conceptuses did not vary between FCG and wild-type matings, suggesting no effect on survival in the model. AGD, a known marker of prenatal androgen exposure (Hotchkiss and Vandenbergh, 2005), varied with the gonadal sex of the fetuses and suggested that sex differences in gonadal hormone levels in the FCG fetuses reflected those in wild-type fetuses. This result has previously been reported in FCG mice at 4 weeks of age (Itoh et al., 2015), but not prenatally. However, a potential caveat regarding the use of the FCG model was that placental weights were lower in FCG pregnancies than in wild-type pregnancies, even in XX female conceptuses, which are expected to be genetically identical in FCG and wild-type matings. Pregnancies sired by FCG and wild-type males involved the same cohort of females and occurred at the same time, indicating that differences in placental weight were due to the males. While FCG and wild-type males shared a C57BL/6J background, it is possible that the Y chromosome deletion and/or Sry transgene affected spermatogenesis leading to epigenetic differences in sperm that affected placental weight. These results illustrate that, while the FCG represents a powerful model for investigating the mechanisms underlying sex differences, it is important to include wild-type controls to assess the extent to which FCG mice reflect wild-type sex differences.

We found little to no effect of gonadal sex on fetal growth, placental growth, or placental gene expression, even though androgen levels differed by gonadal sex, as assessed by AGD. The lack of effect of gonadal sex on placental gene expression is unlikely due to low statistical power given the unusually large size of our RNAseq dataset, which included 28–30 biological replicates per gonadal sex per tissue. Our result regarding gonadal sex is consistent with the finding that sexual dimorphism in placental gene expression does not increase following fetal androgen production in humans (Braun et al., 2021). We expected the placenta to be influenced by the gonadal status of the fetus, given that fetal sex can influence neighboring fetuses (vom Saal et al., 1983; Hotchkiss and Vandenbergh, 2005), and the labyrinth is directly exposed to the fetal circulation. Androgen receptors are present in the human placenta (Meakin and Clifton, 2019; Meakin et al., 2019), although we found the transcript count to be low in the junctional zone/decidua, and undetectable in the labyrinth. Even in the absence of sex steroid receptors, the placenta would be expected to respond to other sexually differentiated signals.

In contrast, XY fetuses and placentas were heavier than their XX counterparts, as previously observed (Ishikawa et al., 2003). Approximately half of the genes showing expression differences between XX and XY placentas were located on either the X or Y chromosome, and some of these were members of homologous X–Y pairs thought to maintain gene dosage (Bellott et al., 2014), i.e. despite showing differential expression, their effect may have been to reduce differences between the sexes.

Given its role in sex-dependent responses to maternal stress (Howerton and Bale, 2014; Bale, 2016), we expected that the X-linked gene Ogt might show a sex-dependent response to maternal nutrition. However, while Ogt expression was higher in XX than in XY placentas, as expected, it was not affected by food restriction. While a previous study found placental Ogt to be upregulated by a high-fat diet and a low-fat diet (compared to an intermediate control) (Mao et al., 2010), other studies have not observed a response to diet (Gabory et al., 2012; de Barros et al., 2020).

Effects of food restriction

As expected, food restriction reduced fetal weight near term, as has previously been observed in mice (Jimenez-Chillaron et al., 2005; Coan et al., 2010; Sferruzzi-Perri et al., 2011; Ganguly et al., 2016; Connor et al., 2020) and rats (Christians et al., 2021). Although we expected nutrient transporter genes to be responsive to food restriction, this was not observed. A less severe degree of food restriction beginning earlier in pregnancy increased the expression of system A amino acid transporter gene Slc38a2 (Sferruzzi-Perri et al., 2011) and the facilitated glucose transporter gene Slc2a1 (Coan et al., 2010), whereas a slightly more severe degree of food restriction decreased the expression of the glucose transporter Slc2a3 (Ganguly et al., 2014). Plasma membrane fatty acid binding protein, Fabppm/Got2, was also previously found to be increased by food restriction (Connor et al., 2020). These previous studies took a targeted, candidate-gene approach in contrast to the transcriptome-wide approach used in the present study.

Conclusions

We did not find evidence of the hypothesized sex differences in fetal growth strategy or their mediation by the placenta (Eriksson et al., 2010; Meakin et al., 2021). Despite the popularity of this hypothesis, it is often not supported by specific tests or systematic reviews in humans or animal models (Christians et al., 2021, 2023; Christians and Chow, 2022; Hercus et al., 2024a). While it is clear that males are overrepresented among adverse pregnancy outcomes, the sex ratio at conception is not different from 50:50, with female-biased mortality early in gestation (Orzack et al., 2015). Thus, the increased frequency of complications among males later in pregnancy may reflect a selection bias, whereby female pregnancies with impaired placentation are lost early, and so are less likely to be included in studies of adverse outcomes such as premature birth and stillbirth.

Sex differences in placental gene expression were largely due to chromosomal sex and not to the gonadal sex of the fetus. Unraveling the mechanisms underlying sex differences will require animal models such as the one we have used. Nevertheless, a primary role for the sex chromosomes may also hold true in humans given that the initiation of fetal androgen production by human male fetuses does not seem to affect sex differences in the placenta (Braun et al., 2021).

Supplementary Material

gaaf015_Supplementary_Data

Acknowledgements

We thank Tara Stach at the UBC School of Biomedical Engineering (SBME) Sequencing Core, Olena Maydan at the BC Children’s Hospital Research Institute Histology Core, and all of the Animal Care staff at Simon Fraser University. We also thank Jorge López-Tello for advice and encouragement regarding placental dissection, Nikita Telkar for help with RNAseq analysis, Michael Love and James MacDonald for helpful explanations at bioconductor.org, and two anonymous reviewers for constructive comments.

Contributor Information

Jess C Hercus, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Daniel Alejandro Salcedo Rubio, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Maria Elisa Osorio Nieto, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Cheayeong Keum, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Qi Wang, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

John A Macdonald, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Jordan S Scott, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Emily R J Lucas, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada.

Julian K Christians, Department of Biological Sciences, Simon Fraser University, Burnaby, BC, Canada; Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, BC, Canada; British Columbia Children’s Hospital Research Institute, Vancouver, BC, Canada; Women’s Health Research Institute, BC Women’s Hospital and Health Centre, Vancouver, BC, Canada.

Supplementary data

Supplementary data are available at Molecular Human Reproduction online.

Data availability

Sequencing data are deposited in the GEO database under accession numbers GSE285453 (labyrinth) and GSE291544 (junctional zone/decidua).

Authors’ roles

J.C.H.: Investigation, formal analysis, manuscript review, and editing; D.A.S.R.: investigation, formal analysis, manuscript review, and editing; M.E.O.N.: investigation, manuscript review, and editing; C.K.: investigation, manuscript review, and editing; Q.W.: investigation, manuscript review, and editing; J.A.M.: investigation, manuscript review, and editing; J.S.S.: investigation, manuscript review, and editing; E.R.J.L.: investigation, manuscript review, and editing; J.K.C.: conceptualization; funding acquisition; formal analysis; writing of original draft.

Funding

Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant and Accelerator Supplement (RGPIN-2021-02853 to J.K.C.), NSERC Canada Graduate Scholarships (Master’s Program Award to J.C.H.); NSERC Undergraduate Student Awards (to C.K. and E.R.J.L.). The funding sources were not involved: in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

Conflict of interest

None declared.

References

  1. Al-Qaraghouli M, Fang YMV.  Effect of fetal sex on maternal and obstetric outcomes. Front Pediatr  2017;5:144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold AP.  Four Core Genotypes and XY mouse models: update on impact on SABV research. Neurosci Biobehav Rev  2020;119:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bale TL.  The placenta and neurodevelopment: sex differences in prenatal vulnerability. Dialogues Clin Neurosci  2016;18:459–464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bellott DW, Hughes JF, Skaletsky H, Brown LG, Pyntikova T, Cho T-J, Koutseva N, Zaghlul S, Graves T, Rock S  et al.  Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature  2014;508:494–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bidne KL, Rister AL, McCain AR, Hitt BD, Dodds ED, Wood JR.  Maternal obesity alters placental lysophosphatidylcholines, lipid storage, and the expression of genes associated with lipid metabolism‡. Biol Reprod  2021;104:197–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blencowe M, Chen X, Zhao Y, Itoh Y, McQuillen CN, Han Y, Shou BL, McClusky R, Reue K, Arnold AP  et al.  Relative contributions of sex hormones, sex chromosomes, and gonads to sex differences in tissue gene regulation. Genome Res  2022;32:807–824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Braun AE, Muench KL, Robinson BG, Wang A, Palmer TD, Winn VD.  Examining sex differences in the human placental transcriptome during the first fetal androgen peak. Reprod Sci  2021;28:801–818. [DOI] [PubMed] [Google Scholar]
  8. Broere-Brown ZA, Adank MC, Benschop L, Tielemans M, Muka T, Gonçalves R, Bramer WM, Schoufour JD, Voortman T, Steegers EAP  et al.  Fetal sex and maternal pregnancy outcomes: a systematic review and meta-analysis. Biol Sex Differ  2020;11:26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Broere-Brown ZA, Baan E, Schalekamp-Timmermans S, Verburg BO, Jaddoe VWV, Steegers EAP.  Sex-specific differences in fetal and infant growth patterns: a prospective population-based cohort study. Biol Sex Differ  2016;7:65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bronson SL, Bale TL.  The placenta as a mediator of stress effects on neurodevelopmental reprogramming. Neuropsychopharmacology  2016;41:207–218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bukowski R, Smith GCS, Malone FD, Ball RH, Nyberg DA, Comstock CH, Hankins GDV, Berkowitz RL, Gross SJ, Dugoff L  et al. ; FASTER Research Consortium. Human sexual size dimorphism in early pregnancy. Am J Epidemiol  2007;165:1216–1218. [DOI] [PubMed] [Google Scholar]
  12. Burgoyne PS, Arnold AP.  A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues. Biol Sex Differ  2016;7:68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Burton GJ, Fowden AL, Thornburg KL.  Placental origins of chronic disease. Physiol Rev  2016;96:1509–1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Catalano PM, Drago NM, Amini SB.  Factors affecting fetal growth and body composition. Am J Obstet Gynecol  1995;172:1459–1463. [DOI] [PubMed] [Google Scholar]
  15. Challis J, Newnham J, Petraglia F, Yeganegi M, Bocking A.  Fetal sex and preterm birth. Placenta  2013;34:95–99. [DOI] [PubMed] [Google Scholar]
  16. Chen H, Boutros PC.  VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics  2011;12:35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cheong JN, Wlodek ME, Moritz KM, Cuffe JSM.  Programming of maternal and offspring disease: impact of growth restriction, fetal sex and transmission across generations. J Physiol  2016;594:4727–4740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chin EH, Christians JK.  When are sex-specific effects really sex-specific?  J Dev Orig Health Dis  2015;6:438–442. [DOI] [PubMed] [Google Scholar]
  19. Chin EH, Schmidt KL, Martel KM, Wong CK, Hamden JE, Gibson WT, Soma KK, Christians JK.  A maternal high-fat, high-sucrose diet has sex-specific effects on fetal glucocorticoids with little consequence for offspring metabolism and voluntary locomotor activity in mice. PLoS One  2017;12:e0174030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Christians JK.  The placenta’s role in sexually dimorphic fetal growth strategies. Reprod Sci  2022;29:1895–1907. [DOI] [PubMed] [Google Scholar]
  21. Christians JK, Ahmadzadeh-Seddeighi S, Bilal A, Bogdanovic A, Ho R, Leung EV, MacGregor MA, Nadasdy NM, Principe GM.  Sex differences in the effects of prematurity and/or low birthweight on neurodevelopmental outcomes: systematic review and meta-analyses. Biol Sex Differ  2023;14:47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Christians JK, Chow NA.  Are there sex differences in fetal growth strategies and in the long-term effects of pregnancy complications on cognitive functioning?  J Dev Orig Health Dis  2022;13:766–778. [DOI] [PubMed] [Google Scholar]
  23. Christians JK, Grynspan D, Greenwood SL, Dilworth MR.  The problem with using the birthweight: placental weight ratio as a measure of placental efficiency. Placenta  2018a;68:52–58. [DOI] [PubMed] [Google Scholar]
  24. Christians JK, Lennie KI, Huicochea Munoz MF, Binning N.  PAPP-A2 deficiency does not exacerbate the phenotype of a mouse model of intrauterine growth restriction. Reprod Biol Endocrinol  2018b;16:58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Christians JK, Reue K.  The role of gonadal hormones and sex chromosomes in sex-dependent effects of early nutrition on metabolic health. Front Endocrinol (Lausanne)  2023;14:1304050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Christians JK, Shergill HK, Albert AYK.  Sex-dependent effects of prenatal food and protein restriction on offspring physiology in rats and mice: systematic review and meta-analyses. Biol Sex Differ  2021;12:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Clifton VL.  Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta  2010;31(Suppl):S33–S39. [DOI] [PubMed] [Google Scholar]
  28. Coan PM, Vaughan OR, Sekita Y, Finn SL, Burton GJ, Constancia M, Fowden AL.  Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J Physiol  2010;588:527–538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Connor KL, Kibschull M, Matysiak-Zablocki E, Nguyen TT-TN, Matthews SG, Lye SJ, Bloise E.  Maternal malnutrition impacts placental morphology and transporter expression: an origin for poor offspring growth. J Nutr Biochem  2020;78:108329. [DOI] [PubMed] [Google Scholar]
  30. de Barros MD, Kusinski LC, Wilsmore P, Loche E, Pantaleão LC, Ashmore TJ, Blackmore HL, Fernandez-Twinn DS, do Carmo MdGT, Ozanne SE.  Impact of maternal obesity on placental transcriptome and morphology associated with fetal growth restriction in mice. Int J Obes  2020;44:1087–1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dearden L, Bouret SG, Ozanne SE.  Sex and gender differences in developmental programming of metabolism. Mol Metab  2018;15:8–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Deegan DF, Engel N.  Sexual dimorphism in the age of genomics: how, when, where. Front Cell Dev Biol  2019;7:186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Denisova EI, Kozhevnikova VV, Bazhan NM, Makarova EN.  Sex-specific effects of leptin administration to pregnant mice on the placentae and the metabolic phenotypes of offspring. FEBS Open Bio  2020;10:96–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Devaskar SU, Chu A.  Intrauterine growth restriction: hungry for an answer. Physiology (Bethesda)  2016;31:131–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. DiPietro JA, Voegtline KM.  The gestational foundation of sex differences in development and vulnerability. Neuroscience  2017;342:4–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Eaton M, Davies AH, Devine J, Zhao X, Simmons DG, Mariusdottir E, Natale DRC, Matyas JR, Bering EA, Workentine ML  et al.  Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction. PLoS One  2020;15:e0226735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Eriksson JG, Kajantie E, Osmond C, Thornburg K, Barker DJP.  Boys live dangerously in the womb. Am J Hum Biol  2010;22:330–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gabory A, Ferry L, Fajardy I, Jouneau L, Gothié JD, Vigé A, Fleur C, Mayeur S, Gallou-Kabani C, Gross MS  et al.  Maternal diets trigger sex-specific divergent trajectories of gene expression and epigenetic systems in mouse placenta. PLoS One  2012;7:e47986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gabory A, Roseboom TJ, Moore T, Moore LG, Junien C.  Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics. Biol Sex Differ  2013;4:5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ganguly A, Chen Y, Shin B-C, Devaskar SU.  Prenatal caloric restriction enhances DNA methylation and MeCP2 recruitment with reduced murine placental glucose transporter isoform 3 expression. J Nutr Biochem  2014;25:259–266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ganguly A, Touma M, Thamotharan S, De Vivo DC, Devaskar SU.  Maternal calorie restriction causing uteroplacental insufficiency differentially affects mammalian placental glucose and leucine transport molecular mechanisms. Endocrinology  2016;157:4041–4054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Gao H, Sathishkumar KR, Yallampalli U, Balakrishnan M, Li X, Wu G, Yallampalli C.  Maternal protein restriction regulates IGF2 system in placental labyrinth. Front Biosci (Elite Ed)  2012;4:1434–1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Gonzalez PN, Gasperowicz M, Barbeito-Andrés J, Klenin N, Cross JC, Hallgrímsson B.  Chronic protein restriction in mice impacts placental function and maternal body weight before fetal growth. PLoS One  2016;11:e0152227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Goyal R, Wong C, Van Wickle J, Longo LD.  Antenatal maternal protein deprivation: sexually dimorphic programming of the pancreatic renin-angiotensin system. J Renin Angiotensin Aldosterone Syst  2013;14:137–145. [DOI] [PubMed] [Google Scholar]
  45. Hercus JC, Metcalfe KX, Christians JK.  Sex differences in growth and mortality in pregnancy-associated hypertension. PLoS One  2024a;19:e0296853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hercus JC, Salcedo Rubio DA, Osorio Nieto ME, Sturn MML, Keum C, Christians JK.  The whole is lesser than the sum of its parts? Dissecting layer-enriched samples of rodent placenta is worth the effort. Placenta  2024b;157:76–80. [DOI] [PubMed] [Google Scholar]
  47. Hiersch L, Melamed N.  Fetal growth velocity and body proportion in the assessment of growth. Am J Obstet Gynecol  2018;218:S700–S711. e1. [DOI] [PubMed] [Google Scholar]
  48. Hotchkiss AK, Vandenbergh JG.  The anogenital distance index of mice (Mus musculus domesticus): an analysis. Contemp Top Lab Anim Sci  2005;44:46–48. [PubMed] [Google Scholar]
  49. Howerton CL, Bale TL.  Targeted placental deletion of OGT recapitulates the prenatal stress phenotype including hypothalamic mitochondrial dysfunction. Proc Natl Acad Sci USA  2014;111:9639–9644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Howerton CL, Morgan CP, Fischer DB, Bale TL.  O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development. Proc Natl Acad Sci USA  2013;110:5169–5174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ishikawa H, Rattigan Á, Fundele R, Burgoyne PS.  Effects of sex chromosome dosage on placental size in mice. Biol Reprod  2003;69:483–488. [DOI] [PubMed] [Google Scholar]
  52. Itoh Y, Mackie R, Kampf K, Domadia S, Brown JD, O’Neill R, Arnold AP.  Four Core Genotypes mouse model: localization of the Sry transgene and bioassay for testicular hormone levels. BMC Res Notes  2015;8:69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Jimenez-Chillaron JC, Hernandez-Valencia M, Reamer C, Fisher S, Joszi A, Hirshman M, Oge A, Walrond S, Przybyla R, Boozer C  et al.  Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model. Diabetes  2005;54:702–711. [DOI] [PubMed] [Google Scholar]
  54. Kalisch-Smith JI, Simmons DG, Dickinson H, Moritz KM.  Review: sexual dimorphism in the formation, function and adaptation of the placenta. Placenta  2017;54:10–16. [DOI] [PubMed] [Google Scholar]
  55. Kiserud T, Piaggio G, Carroli G, Widmer M, Carvalho J, Neerup Jensen L, Giordano D, Cecatti JG, Abdel Aleem H, Talegawkar SA  et al.  The World Health Organization fetal growth charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight. PLoS Med  2017;14:e1002220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, Peterson H.  g: Profiler—interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res  2023;51:W207–W212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Kozhemiako N, Nunes AS, Vakorin VA, Chau CMY, Moiseev A, Ribary U, Grunau RE, Doesburg SM.  Sex differences in brain connectivity and male vulnerability in very preterm children. Hum Brain Mapp  2020;41:388–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Love MI, Huber W, Anders S.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol  2014;15:550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Mao J, Zhang X, Sieli PT, Falduto MT, Torres KE, Rosenfeld CS.  Contrasting effects of different maternal diets on sexually dimorphic gene expression in the murine placenta. Proc Natl Acad Sci USA  2010;107:5557–5562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Mauvais-Jarvis F, Arnold AP, Reue K.  A guide for the design of pre-clinical studies on sex differences in metabolism. Cell Metab  2017;25:1216–1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. McFarlane L, Truong V, Palmer JS, Wilhelm D.  Novel PCR assay for determining the genetic sex of mice. Sex Dev  2013;7:207–211. [DOI] [PubMed] [Google Scholar]
  62. McWhorter ES, Russ JE, Winger QA, Bouma GJ.  Androgen and estrogen receptors in placental physiology and dysfunction. Front Biol  2018;13:315–326. [Google Scholar]
  63. Meakin AS, Clifton VL.  Review: understanding the role of androgens and placental AR variants: Insight into steroid-dependent fetal-placental growth and development. Placenta  2019;84:63–68. [DOI] [PubMed] [Google Scholar]
  64. Meakin AS, Cuffe JSM, Darby JRT, Morrison JL, Clifton VL.  Let’s talk about placental sex, baby: understanding mechanisms that drive female- and male-specific fetal growth and developmental outcomes. Int J Mol Sci  2021;22:6386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Meakin AS, Saif Z, Tuck AR, Clifton VL.  Human placental androgen receptor variants: potential regulators of male fetal growth. Placenta  2019;80:18–26. [DOI] [PubMed] [Google Scholar]
  66. Mondal D, Galloway TS, Bailey TC, Mathews F.  Elevated risk of stillbirth in males: systematic review and meta-analysis of more than 30 million births. BMC Med  2014;12:220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Morton JS, Cooke C-L, Davidge ST.  In utero origins of hypertension: mechanisms and targets for therapy. Physiol Rev  2016;96:549–603. [DOI] [PubMed] [Google Scholar]
  68. Nugent BM, O’Donnell CM, Epperson CN, Bale TL.  Placental H3K27me3 establishes female resilience to prenatal insults. Nat Commun  2018;9:2555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Orzack SH, Stubblefield JW, Akmaev VR, Colls P, Munné S, Scholl T, Steinsaltz D, Zuckerman JE.  The human sex ratio from conception to birth. Proc Natl Acad Sci USA  2015;112:E2102–E2111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Panten J, Del Prete S, Cleland JP, Saunders LM, van Riet J, Schneider A, Ginno P, Schneider N, Koch M-L, Chen X  et al.  Four Core Genotypes mice harbour a 3.2MB X-Y translocation that perturbs Tlr7 dosage. Nat Commun  2024;15:8814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pérez-Cerezales S, Ramos-Ibeas P, Rizos D, Lonergan P, Bermejo-Alvarez P, Gutiérrez-Adán A.  Early sex-dependent differences in response to environmental stress. Reproduction  2018;155:R39–R51. [DOI] [PubMed] [Google Scholar]
  72. Phuthong S, Reyes-Hernandez CG, Rodriguez-Rodriguez P, Ramiro-Cortijo D, Gil-Ortega M, Gonzalez-Blazquez R, Gonzalez MC, Pablo ALd, Arribas SM.  Sex differences in placental protein expression and efficiency in a rat model of fetal programming induced by maternal undernutrition. Int J Mol Sci  2020;22:237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Reue K, Wiese CB.  Illuminating the mechanisms underlying sex differences in cardiovascular disease. Circ Res  2022;130:1747–1762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Rosenfeld CS.  Sex-specific placental responses in fetal development. Endocrinology  2015;156:3422–3434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Sandman CA, Glynn LM, Davis EP.  Is there a viability-vulnerability tradeoff? Sex differences in fetal programming. J Psychosom Res  2013;75:327–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Sferruzzi-Perri AN, Vaughan OR, Coan PM, Suciu MC, Darbyshire R, Constancia M, Burton GJ, Fowden AL.  Placental-specific Igf2 deficiency alters developmental adaptations to undernutrition in mice. Endocrinology  2011;152:3202–3212. [DOI] [PubMed] [Google Scholar]
  77. Soneson C, Love MI, Robinson MD.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res  2015;4:1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Stevenson DK, Verter J, Fanaroff AA, Oh W, Ehrenkranz RA, Shankaran S, Donovan EF, Wright LL, Lemons JA, Tyson JE  et al.  Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed  2000;83:F182–F185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Sutherland S, Brunwasser SM.  Sex differences in vulnerability to prenatal stress: a review of the recent literature. Curr Psychiatry Rep  2018;20:102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Tarrade A, Panchenko P, Junien C, Gabory A.  Placental contribution to nutritional programming of health and diseases: epigenetics and sexual dimorphism. J Exp Biol  2015;218:50–58. [DOI] [PubMed] [Google Scholar]
  81. Van Gronigen Case G, Storey KM, Parmeley LE, Schulz LC.  Effects of maternal nutrient restriction during the periconceptional period on placental development in the mouse. PLoS One  2021;16:e0244971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Verburg PE, Tucker G, Scheil W, Erwich JJHM, Dekker GA, Roberts CT.  Sexual dimorphism in adverse pregnancy outcomes—a retrospective Australian population study 1981-2011. PLoS One  2016;11:e0158807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Vickers MH, Clayton ZE, Yap C, Sloboda DM.  Maternal fructose intake during pregnancy and lactation alters placental growth and leads to sex-specific changes in fetal and neonatal endocrine function. Endocrinology  2011;152:1378–1387. [DOI] [PubMed] [Google Scholar]
  84. Vom Saal FS, Grant WM, McMullen CW, Laves KS.  High fetal estrogen concentrations: correlation with increased adult sexual activity and decreased aggression in male mice. Science  1983;220:1306–1309. [DOI] [PubMed] [Google Scholar]
  85. Voskamp BJ, Peelen MJCS, Ravelli ACJ, R van der L, Mol BWJ, Pajkrt E, Ganzevoort W, Kazemier BM.  Association between fetal sex, birthweight percentile and adverse pregnancy outcome. Acta Obstet Gynecol Scand  2020;99:48–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Wickham H.  ggplot2: Elegant Graphics for Data Analysis. 2016. New York, NY, USA: Springer-Verlag. https://ggplot2.tidyverse.org. [Google Scholar]
  87. Wolstenholme JT, Rissman EF, Bekiranov S.  Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. Genes Brain Behav  2013;12:166–180. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

gaaf015_Supplementary_Data

Data Availability Statement

Sequencing data are deposited in the GEO database under accession numbers GSE285453 (labyrinth) and GSE291544 (junctional zone/decidua).


Articles from Molecular Human Reproduction are provided here courtesy of Oxford University Press

RESOURCES